MPM ASSET MANAGEMENT LLC - Q4 2022 holdings

$239 Million is the total value of MPM ASSET MANAGEMENT LLC's 9 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 0.0% .

 Value Shares↓ Weighting
 Entrada Therapeutics, Inc.$59,836,600
-14.2%
4,425,7840.0%25.04%
-5.8%
DYN  Dyne Therapeutics, Inc.$57,385,602
-8.7%
4,951,3030.0%24.01%
+0.3%
ITOS  iTeos Therapeutics, Inc.$53,488,471
+2.5%
2,738,7850.0%22.38%
+12.6%
RPTX  Repare Therapeutics, Inc.$32,989,176
+21.3%
2,242,6360.0%13.80%
+33.2%
AMYT  Amryt Pharma plc$19,482,554
+5.5%
2,668,8430.0%8.15%
+15.9%
HOWL  Werewolf Therapeutics, Inc.$8,782,553
-54.5%
4,284,1720.0%3.68%
-50.1%
TCRR  TCR2 Therapeutics, Inc.$4,046,814
-44.5%
4,050,8650.0%1.69%
-39.0%
HARP  Harpoon Therapeutics, Inc.$2,273,388
-25.1%
3,131,3880.0%0.95%
-17.8%
ONCR  Oncorus, Inc.$720,914
-70.2%
2,849,4640.0%0.30%
-67.2%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Chiasma, Inc.24Q2 202119.8%
Aratana Therapeutics, Inc.24Q1 201926.8%
Conatus Pharmaceuticals, Inc.23Q1 20199.7%
Rhythm Pharmaceuticals, Inc.19Q2 202269.9%
Harpoon Therapeutics, Inc.19Q3 202331.9%
Syndax Pharmaceuticals, Inc.19Q3 202014.5%
Radius Health, Inc.17Q2 201876.4%
TCR2 Therapeutics, Inc.17Q1 202329.1%
Proteon Therapeutics, Inc.17Q4 20183.0%
EpiZyme, Inc.15Q4 201635.9%

View MPM ASSET MANAGEMENT LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR/A2023-09-07
13F-HR2023-08-14
42023-06-05
42023-05-24
13F-HR2023-05-12
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11

View MPM ASSET MANAGEMENT LLC's complete filings history.

Compare quarters

Export MPM ASSET MANAGEMENT LLC's holdings